全文获取类型
收费全文 | 39603篇 |
免费 | 2616篇 |
国内免费 | 127篇 |
专业分类
耳鼻咽喉 | 371篇 |
儿科学 | 974篇 |
妇产科学 | 939篇 |
基础医学 | 5146篇 |
口腔科学 | 646篇 |
临床医学 | 3805篇 |
内科学 | 7654篇 |
皮肤病学 | 588篇 |
神经病学 | 4111篇 |
特种医学 | 1281篇 |
外科学 | 6502篇 |
综合类 | 468篇 |
现状与发展 | 1篇 |
一般理论 | 35篇 |
预防医学 | 3270篇 |
眼科学 | 1017篇 |
药学 | 2649篇 |
中国医学 | 114篇 |
肿瘤学 | 2775篇 |
出版年
2023年 | 224篇 |
2022年 | 399篇 |
2021年 | 882篇 |
2020年 | 543篇 |
2019年 | 799篇 |
2018年 | 1013篇 |
2017年 | 719篇 |
2016年 | 721篇 |
2015年 | 855篇 |
2014年 | 1328篇 |
2013年 | 1718篇 |
2012年 | 2797篇 |
2011年 | 2922篇 |
2010年 | 1645篇 |
2009年 | 1483篇 |
2008年 | 2663篇 |
2007年 | 2852篇 |
2006年 | 2673篇 |
2005年 | 2621篇 |
2004年 | 2502篇 |
2003年 | 2370篇 |
2002年 | 2170篇 |
2001年 | 379篇 |
2000年 | 333篇 |
1999年 | 384篇 |
1998年 | 441篇 |
1997年 | 388篇 |
1996年 | 379篇 |
1995年 | 310篇 |
1994年 | 300篇 |
1993年 | 262篇 |
1992年 | 225篇 |
1991年 | 190篇 |
1990年 | 157篇 |
1989年 | 144篇 |
1988年 | 164篇 |
1987年 | 150篇 |
1986年 | 135篇 |
1985年 | 144篇 |
1984年 | 148篇 |
1983年 | 160篇 |
1982年 | 193篇 |
1981年 | 172篇 |
1980年 | 146篇 |
1979年 | 86篇 |
1978年 | 114篇 |
1977年 | 116篇 |
1976年 | 87篇 |
1975年 | 89篇 |
1974年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
Kallol Ray Chaudhuri Pablo Martinez-Martin Anthony H V Schapira Fabrizio Stocchi Kapil Sethi Per Odin Richard G Brown William Koller Paolo Barone Graeme MacPhee Linda Kelly Martin Rabey Doug MacMahon Sue Thomas William Ondo David Rye Alison Forbes Susanne Tluk Vandana Dhawan Annette Bowron Adrian J Williams Charles W Olanow 《Movement disorders》2006,21(7):916-923
Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. There is no single instrument (questionnaire or scale) that enables a comprehensive assessment of the range of NMS in PD both for the identification of problems and for the measurement of outcome. Against this background, a multidisciplinary group of experts, including patient group representatives, has developed an NMS screening questionnaire comprising 30 items. This instrument does not provide an overall score of disability and is not a graded or rating instrument. Instead, it is a screening tool designed to draw attention to the presence of NMS and initiate further investigation. In this article, we present the results from an international pilot study assessing feasibility, validity, and acceptability of a nonmotor questionnaire (NMSQuest). Data from 123 PD patients and 96 controls were analyzed. NMS were highly significantly more prevalent in PD compared to controls (PD NMS, median = 9.0, mean = 9.5 vs. control NMS, median = 5.5, mean = 4.0; Mann-Whitney, Kruskal-Wallis, and t test, P < 0.0001), with PD patients reporting at least 10 different NMS on average per patient. In PD, NMS were highly significantly more prevalent across all disease stages and the number of symptoms correlated significantly with advancing disease and duration of disease. Furthermore, frequently, problems such as diplopia, dribbling, apathy, blues, taste and smell problems were never previously disclosed to the health professionals. 相似文献
74.
Richard M. Kawamoto J. -P. Brunschwig Anthony H. Caswell 《Journal of muscle research and cell motility》1988,9(4):334-343
Summary Polyclonal antibodies have been developed against the junctional feet or spanning protein from skeletal muscle triads. These probes in combination with immunogold labels have been used to localize the spanning protein by electron microscope of isolated vesicles from terminal cisternae/triads. The spanning protein antibodies specifically bind to the electron dense junctional feet. In vesicles permeabilized by hypotonic treatment or by saponin, some gold particles may be seen on the luminal side of the vesicle. Trypsin treatment of vesicles causes complete loss of the 300 K spanning protein from SDS gels while dot blots show that some but not all the antigenic activity is lost. This treatment is associated with the loss of the electron dense projections from the membrane surface and is coincident with the loss of immunogold staining when antibody is added to the intact vesicles. On the other hand, in experiments in which the luminal portions of the isolated vesicles have been made accessible to the polyclonal antibodies by sectioning lightly fixed vesicles before immunogold tagging, extensive gold labelling was found to occur in trypsin treated vesicles which have lost detectable projections from the cytoplasmic side of the membrane. These data support the view that the spanning protein projects from the sarcoplasmic reticulum towards the transverse tubules but further suggest that spanning protein extends into and probably through the sarcoplasmic reticulum membrane in accord with the proposition that it is a Ca2+ channel.Nomenclature SP
spanning protein
- SR
sarcoplasmic reticulum
- TC
terminal cisternae
- T-tubule
transverse tubule
- HMW
high molecular weight
- ELISA
enzyme linked immunosorbent assay
- PMSF
phenylmethyl sulphonylfluoride
- SDS
sodium dodecyle sulphate 相似文献
75.
In children with acute obstructive lung disease gas exchange is affected by ventilation-perfusion mismatch and the degree of bronchoconstriction. Standard lung function measurements do not reflect the impairment in gas exchange. Alternatively, the effective pulmonary blood flow (EPBF), that is, the proportion of the cardiac output that is supplying well-ventilated lung units, can give accurate and noninvasive estimates of ventilation-perfusion mismatch. We measured EPBF with the argon freon ?22 rebreathing technique in children with acute severe asthma to assess their response to nebulized salbutamol and to determine whether induced changes in the EPBF could be predicted from baseline measurements. Twenty-four children admitted with an acute asthma attack had spirometry and triplicate EPBF measurements before and after nebulized salbutamol. Eighteen patients had repeated tests 50 days later when fully recovered; 4 patients were taking methylxanthines on at least one occasion. The mean forced expiratory volume in 1 sec (FEV1) rose from 55% of predicted to 66% after salbutamol and to 83% with recovery. The mean coefficients of variation for EPBF measurements on the three test occasions were 11.3%, 8.2%, and 9%. Except in children on methylxanthines, the EPBF values were reduced during the acute asthma attack (median, 2.53 L/min/m2; range, 1.99–3.60 L/min/m2) compared with paired values obtained after recovery (median, 2.89 L/min/m2; range, 2.2Eb4.04 L/min/m2) (P = 0.009). Salbutamol caused a highly significant increase in EPBF from 2.88 L/min/m2 (range, 1.86–3.80) before treatment to 3.34 L/min/m2 (range, 2.264.65) immediately afterwards (P = 0.0003). The spirometric indices did not relate to the changes in the EPBF values. However, when the effective stroke volume index was calculated in 11 patients, the changes induced by nebulized salbutamol had a significant inverse relation with the pretreatment FEV, (P = 0.61; P = 0.02). In conclusion, the argon freon-22 rebreathing technique can be used successfully and reproducibly to measure EPBF in children with an acute asthma attack. Except in children taking methylxanthines, EPBF during the acute attack is reduced and rises significantly after salbutamol. EPBF values after recovery were significantly higher than the presalbutamol values during the attack. Spirometric indices do not relate to the EPBF changes but are inversely related to the effective stroke volume changes. Pediatr Pulmonol. 1994; 17:370–377. © 1994 Wiley-Liss, Inc. 相似文献
76.
M Hatem F Anthony P Hogston D J Rowe K J Dennis 《British medical journal (Clinical research ed.)》1988,296(6623):676-678
A 75 g oral glucose tolerance test was performed in 212 pregnant women with no predisposing factors suggesting glucose intolerance to establish the normal pattern of glucose metabolism in pregnancy. Reference values for the test were established for the middle of pregnancy (14-20 weeks, n = 43) and late pregnancy (28-37 weeks, n = 168). One woman was excluded because she had diabetes that required treatment with insulin. There were statistically significant differences between the two groups for samples taken both one and two hours after the glucose load. Reference ranges for the interpretation of the glucose tolerance test in pregnancy should therefore take account of the period of gestation. Arbitrary upper limits of normal (represented by the 97.5 centile) two hours after a 75 g oral glucose load are proposed at 7.5 and 9.6 mmol/l for the second and third trimesters, respectively. 相似文献
77.
78.
J. A. Doebler W. R. Markesbery A. Anthony S. W. Scheff R. E. Rhoads 《Acta neuropathologica》1988,75(3):272-276
Summary A new double-staining procedure, in which the techniques of immunocytochemistry of glial fibrillary acidic protein (GFAP) and quantitative microdensitometry of azure B-RNA were combined, was used to study nucleic acid alterations in fibrous astrocytes in Alzheimer's disease (AD). RNA contents of GFAP-positive cells of the hippocampal endplate (Rose's H3-H5 fields) and the dentate gyrus molecular layer were determined in ten autopsy-proven AD patients (ages 51–88) and ten age-matched, non-demented control. In addition, RNA contents of pyramidal neurons of the endplate were examined. While there were no differences in RNA contents of astrocytes of either region between AD patients and controls, neuronal RNA was markedly depleted. These data suggest that astrocytes maintain protein synthetic capabilities in AD and that RNA loss is limited to the neuronal compartment.Supported by Grants 1P01-AG05119 and 1P50-AG05144 from the National Institutes of Health and by a Small Research Project Award from the University of Kentucky Medical Center 相似文献
79.
80.
K Michael Cummings Anthony Brown Richard O'Connor 《Cancer epidemiology, biomarkers & prevention》2007,16(6):1070-1076
This study examines the history of the cigarette controversy using the tobacco documents as a roadmap to explore the following four questions: (a) What did tobacco companies know about the health risks of smoking and when did they know it? (b) What evidence is there that tobacco companies conspired to deliberately mislead the public about the health risks of smoking? (c) How were scientists involved in the cigarette controversy? (d) Have tobacco companies changed the way they do business since signing the 1998 Master Settlement Agreement? The tobacco companies knew and for most part accepted the evidence that cigarette smoking was a cause of cancer by the late 1950s. The documents also reveal that the tobacco companies helped manufacture the smoking controversy by funding scientific research that was intended to obfuscate and prolong the debate about smoking and health. Today, the tobacco companies acknowledge that smoking is a cause of disease, but they have not materially altered the way they do business. In our opinion, it is not sufficient for the tobacco industry to merely concede the obvious point that smoking is a cause of disease when it is evident that decades of misinformation has resulted in a public that is massively ignorant about the risks of smoking low-tar cigarettes, nicotine addiction, and secondhand smoke exposure. Public education efforts are still needed to correct these misperceptions along with government oversight to ensure that the industry is not permitted to mislead the public further. If the past 50 years have taught us anything, it is that the tobacco industry cannot be trusted to put the public's interest above their profits no matter what they say. 相似文献